Publications of Matthias Lienhard
All genres
Journal Article (37)
1.
Journal Article
34 (11), pp. 1832 - 1848 (2024)
Long-read transcriptome sequencing of CLL and MDS patients uncovers molecular effects of SF3B1 mutations. Genome Research 2.
Journal Article
21 (7), pp. 1349 - 1363 (2024)
Systematic assessment of long-read RNA-seq methods for transcript identification and quantification. Nature Methods 3.
Journal Article
73 (7), pp. 1058 - 1071 (2024)
Depletion of TBC1D4 improves the metabolic exercise response by overcoming genetically induced peripheral insulin resistance. Diabetes 4.
Journal Article
6 (2), Article lqae043 (2024)
Cancer drug sensitivity estimation using modular deep Graph Neural Networks. NAR: Genomics and Bioinformatics 5.
Journal Article
15 (1), 1393 (2024)
Neurofibromin 1 controls metabolic balance and Notch-dependent quiescence of murine juvenile myogenic progenitors. Nature Communications 6.
Journal Article
39 (6), btad364 (2023)
IsoTools: a flexible workflow for long-read transcriptome sequencing analysis. Bioinformatics 7.
Journal Article
22, 17 (2023)
Deletion of Tbc1d4/As160 abrogates cardiac glucose uptake and increases myocardial damage after ischemia/reperfusion. Cardiovascular Diabetology 8.
Journal Article
140 (20), pp. 2113 - 2126 (2022)
Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies. Blood 9.
Journal Article
9, 699 (2022)
Multi-omics HeCaToS dataset of repeated dose toxicity for cardiotoxic & hepatotoxic compounds. Scientific Data 10.
Journal Article
14 (16), 3950 (2022)
Pre-Training on In Vitro and Fine-Tuning on Patient-Derived Data Improves Deep Neural Networks for Anti-Cancer Drug-Sensitivity Prediction. Cancers / Molecular Diversity Preservation International (MDPI) 11.
Journal Article
27 (6), 173 (2022)
Epirubicin Alters DNA Methylation Profiles Related to Cardiotoxicity. Frontiers in Bioscience-Landmark 12.
Journal Article
4 (1), lqab128 (2022)
Matching anticancer compounds and tumor cell lines by neural networks with ranking loss. NAR: genomics and bioinformatics 13.
Journal Article
22 (17), 9337 (2021)
Altered DNA Methylation Profiles in SF3B1 Mutated CLL Patients. International Journal of Molecular Sciences 14.
Journal Article
19, 19:274 (2021)
Large-scale literature mining to assess the relation between anti-cancer drugs and cancer types. Journal of Translational Medicine 15.
Journal Article
12, 3307 (2021)
Crowdsourced mapping of unexplored target space of kinase inhibitors. Nature Communications 16.
Journal Article
81 (1), pp. 38 - 49 (2021)
PWD/Ph-encoded genetic variants modulate the cellular Wnt/β-Catenin response to suppress ApcMin-triggered intestinal tumor formation. Cancer research: an official organ of the American Association for Cancer Research 17.
Journal Article
3 (1), 573 (2020)
Network integration and modelling of dynamic drug responses at multi-omics levels. Communications Biology 18.
Journal Article
9 (9), 4641 (2019)
DMSO induces drastic changes in human cellular processes and epigenetic landscape in vitro. Scientific Reports 19.
Journal Article
21 (2), pp. 198 - 213 (2019)
Combined Targeted Re-Sequencing of Cytosine DNA Methylation and Mutations of DNA Repair Genes with Potential Use for PARP1 Inhibitor Sensitivity Testing. The Journal of Molecular Diagnostics 20.
Journal Article
21 (2), pp. 198 - 213 (2019)
Combined Targeted Resequencing of Cytosine DNA Methylation and Mutations of DNA Repair Genes with Potential Use for Poly(ADP-Ribose) Polymerase 1 Inhibitor Sensitivity Testing. The Journal of Molecular Diagnostics